Robert Tosiello
Sunovion (United Kingdom)(GB)Sunovion (United States)(US)Vion Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Epilepsy research and treatment, Inhalation and Respiratory Drug Delivery, Respiratory Support and Mechanisms, Pneumonia and Respiratory Infections
Most-Cited Works
- → A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women(1999)167 cited
- → Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models(2013)148 cited
- → Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis(1999)107 cited
- → Randomized, Double‐Blind Study of Ciprofloxacin and Cefuroxime Axetil for Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis(1998)83 cited
- → Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia(1997)53 cited
- → Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials(2017)39 cited